A

Apogee Therapeutics, Inc.

Health

Apogee Therapeutics, Inc. is focused on developing innovative therapies for atopic dermatitis and other conditions. The company is expanding its clinical trials into asthma and eosinophilic esophagitis (EoE), supported by a significant funding deal with Blackstone.

$1.3BVisit website ↗

Funding history

  1. $1.3B2026-06-03
    Source: news.google.com ↗

Investors in Apogee Therapeutics, Inc.

Backers from this company's tracked funding rounds.

  • Blackstone

More Health companies

Recently funded startups in the same category.

Related on Datapile